EIR GlaxoSmithKline Apr 2003

Jawaid Hamid FDA$595.00 - Available Now

FDA investigators audited the GlaxoSmithKline - Zebulon, NC, United States facility and issued inspectional observation (via FDA 483) on 17 Apr 2003.

Product details

  • Category:
  • Inspection end: 17 Apr 2003
  • Location: Zebulon, United States
  • FEI: 1033964
Add To Cart